Global Influenza Medication Market Growth 2025-2031
Description
The global Influenza Medication market size is predicted to grow from US$ 3578 million in 2025 to US$ 5292 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
LP Information, Inc. (LPI) ' newest research report, the “Influenza Medication Industry Forecast” looks at past sales and reviews total world Influenza Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Influenza Medication sales for 2025 through 2031. With Influenza Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Medication industry.
This Insight Report provides a comprehensive analysis of the global Influenza Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Segmentation by Application:
Hospitals
Clinics
Pharmacies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Key Questions Addressed in this Report
What is the 10-year outlook for the global Influenza Medication market?
What factors are driving Influenza Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Medication market opportunities vary by end market size?
How does Influenza Medication break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
LP Information, Inc. (LPI) ' newest research report, the “Influenza Medication Industry Forecast” looks at past sales and reviews total world Influenza Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Influenza Medication sales for 2025 through 2031. With Influenza Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Medication industry.
This Insight Report provides a comprehensive analysis of the global Influenza Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Segmentation by Application:
Hospitals
Clinics
Pharmacies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Key Questions Addressed in this Report
What is the 10-year outlook for the global Influenza Medication market?
What factors are driving Influenza Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Medication market opportunities vary by end market size?
How does Influenza Medication break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
105 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Influenza Medication by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Influenza Medication by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
